Profile | GDS5420 / 230634_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 446.87 | 65 |
GSM1296119 | B_lesional_pre-dose | 148.9 | 47 |
GSM1296076 | C_lesional_pre-dose | 217.91 | 55 |
GSM1296092 | D_lesional_pre-dose | 493.86 | 68 |
GSM1296103 | E_lesional_pre-dose | 339.69 | 61 |
GSM1296078 | F_lesional_pre-dose | 211.19 | 55 |
GSM1296107 | G_lesional_pre-dose | 205.18 | 52 |
GSM1296109 | H_lesional_pre-dose | 421.85 | 64 |
GSM1296080 | I_lesional_pre-dose | 593.09 | 71 |
GSM1296090 | J_lesional_pre-dose | 350.15 | 62 |
GSM1296074 | K_lesional_pre-dose | 244.33 | 58 |
GSM1296111 | L_lesional_pre-dose | 168.14 | 48 |
GSM1296099 | M_lesional_pre-dose | 320.75 | 60 |
GSM1296086 | O_lesional_pre-dose | 489.93 | 68 |
GSM1296117 | P_lesional_pre-dose | 215.04 | 53 |
GSM1296113 | Q_lesional_pre-dose | 223.64 | 52 |
GSM1296096 | R_lesional_pre-dose | 305.7 | 59 |
GSM1296105 | S_lesional_pre-dose | 274.64 | 57 |
GSM1296098 | T_lesional_pre-dose | 357.95 | 62 |
GSM1296101 | U_lesional_pre-dose | 367.01 | 62 |
GSM1296121 | V_lesional_pre-dose | 179.63 | 50 |
GSM1296088 | W_lesional_pre-dose | 383.36 | 63 |
GSM1296082 | X_lesional_pre-dose | 440.06 | 66 |
GSM1296115 | Y_lesional_pre-dose | 271.39 | 57 |
GSM1296084 | Z_lesional_pre-dose | 516.02 | 68 |
GSM1296072 | B_lesional_day8 | 127.78 | 44 |
GSM1296069 | L_lesional_day8 | 125.84 | 42 |
GSM1296071 | P_lesional_day8 | 189.1 | 49 |
GSM1296070 | Y_lesional_day8 | 213.92 | 52 |
GSM1296073 | V_lesional_day8 | 165.84 | 50 |
GSM1296034 | A_lesional_day15 | 427.8 | 64 |
GSM1296041 | G_lesional_day15 | 251.34 | 56 |
GSM1296035 | R_lesional_day15 | 276.52 | 58 |
GSM1296038 | U_lesional_day15 | 215.12 | 54 |
GSM1296047 | B_lesional_day15 | 124.56 | 43 |
GSM1296039 | E_lesional_day15 | 221.61 | 54 |
GSM1296042 | H_lesional_day15 | 188.54 | 50 |
GSM1296043 | L_lesional_day15 | 200.03 | 51 |
GSM1296037 | M_lesional_day15 | 260.98 | 56 |
GSM1296046 | P_lesional_day15 | 146.7 | 45 |
GSM1296044 | Q_lesional_day15 | 183.19 | 49 |
GSM1296045 | Y_lesional_day15 | 153.12 | 46 |
GSM1296025 | C_lesional_day15 | 257.59 | 57 |
GSM1296033 | D_lesional_day15 | 549.81 | 69 |
GSM1296027 | I_lesional_day15 | 478.11 | 67 |
GSM1296032 | J_lesional_day15 | 395.48 | 63 |
GSM1296024 | K_lesional_day15 | 215.48 | 54 |
GSM1296031 | W_lesional_day15 | 288.4 | 58 |
GSM1296028 | X_lesional_day15 | 449.51 | 66 |
GSM1296029 | Z_lesional_day15 | 469.85 | 66 |
GSM1296026 | F_lesional_day15 | 214.21 | 54 |
GSM1296030 | O_lesional_day15 | 547.02 | 69 |
GSM1296040 | S_lesional_day15 | 523.85 | 68 |
GSM1296036 | T_lesional_day15 | 330.87 | 60 |
GSM1296048 | V_lesional_day15 | 146.2 | 47 |
GSM1296059 | A_lesional_day43 | 405.1 | 64 |
GSM1296066 | G_lesional_day43 | 191.24 | 50 |
GSM1296060 | R_lesional_day43 | 270.35 | 57 |
GSM1296063 | U_lesional_day43 | 162.47 | 49 |
GSM1296064 | E_lesional_day43 | 176.06 | 51 |
GSM1296067 | H_lesional_day43 | 198.29 | 50 |
GSM1296062 | M_lesional_day43 | 381.01 | 62 |
GSM1296068 | Q_lesional_day43 | 143.05 | 44 |
GSM1296050 | C_lesional_day43 | 130.56 | 45 |
GSM1296057 | D_lesional_day43 | 174.52 | 50 |
GSM1296052 | I_lesional_day43 | 393.87 | 64 |
GSM1296054 | J_lesional_day43 | 353.05 | 61 |
GSM1296049 | K_lesional_day43 | 224.1 | 54 |
GSM1296055 | W_lesional_day43 | 159.7 | 48 |
GSM1296053 | X_lesional_day43 | 492.36 | 67 |
GSM1296058 | Z_lesional_day43 | 242.64 | 56 |
GSM1296051 | F_lesional_day43 | 198.4 | 53 |
GSM1296056 | O_lesional_day43 | 210.14 | 54 |
GSM1296065 | S_lesional_day43 | 235.11 | 55 |
GSM1296061 | T_lesional_day43 | 377.27 | 62 |
GSM1296095 | A_non-lesional_pre-dose | 334.92 | 61 |
GSM1296120 | B_non-lesional_pre-dose | 122.81 | 43 |
GSM1296077 | C_non-lesional_pre-dose | 181.88 | 52 |
GSM1296093 | D_non-lesional_pre-dose | 408.57 | 64 |
GSM1296104 | E_non-lesional_pre-dose | 215.49 | 53 |
GSM1296079 | F_non-lesional_pre-dose | 176.6 | 51 |
GSM1296108 | G_non-lesional_pre-dose | 193.83 | 51 |
GSM1296110 | H_non-lesional_pre-dose | 230.38 | 53 |
GSM1296081 | I_non-lesional_pre-dose | 517.55 | 68 |
GSM1296091 | J_non-lesional_pre-dose | 395.12 | 64 |
GSM1296075 | K_non-lesional_pre-dose | 203.34 | 54 |
GSM1296112 | L_non-lesional_pre-dose | 170.82 | 47 |
GSM1296100 | M_non-lesional_pre-dose | 249.1 | 55 |
GSM1296087 | O_non-lesional_pre-dose | 632.57 | 72 |
GSM1296118 | P_non-lesional_pre-dose | 242.45 | 54 |
GSM1296114 | Q_non-lesional_pre-dose | 170.07 | 48 |
GSM1296097 | R_non-lesional_pre-dose | 135.8 | 46 |
GSM1296106 | S_non-lesional_pre-dose | 235.14 | 54 |
GSM1296102 | U_non-lesional_pre-dose | 254.45 | 55 |
GSM1296122 | V_non-lesional_pre-dose | 131.39 | 44 |
GSM1296089 | W_non-lesional_pre-dose | 323.38 | 60 |
GSM1296083 | X_non-lesional_pre-dose | 530.95 | 68 |
GSM1296116 | Y_non-lesional_pre-dose | 156.11 | 46 |
GSM1296085 | Z_non-lesional_pre-dose | 421.87 | 65 |